Clear Street Raises PT on Beam Therapeutics (BEAM) to $37 Following Q3 Results

Published 2 hours ago Neutral
Clear Street Raises PT on Beam Therapeutics (BEAM) to $37 Following Q3 Results
With significant upside potential and hedge fund interest, Beam Therapeutics Inc. (NASDAQ:BEAM) secured a spot on our list of the 15 stocks set to explode in 2026.Clear Street Raises PT on Beam Therapeutics (BEAM) to $37 Following Q3 Results

On November 5, 2025, Clear Street increased its price target on Beam Therapeutics Inc. (NASDAQ:BEAM) from $34 to $37, while maintaining a “Buy” rating.

The revised target reflected the company’s robust performance in the third quarter of 2025. The investment firm pointed toward the first patient dosing in Beam Therapeutics Inc. (NASDAQ:BEAM)’s BEAM-103 healthy volunteer study, which is a key achievement in its ESCAPE platform. Furthermore, Clear Street highlighted the company’s upcoming BEAM-302 interim update in early 2026 as a key catalyst. The firm also praised the company’s increased strength in its balance sheet, evident from its 17% stake in Orbital Therapeutics, which is valued at roughly $255 million following its $1.5 billion buyout by Bristol Myers Squibb.

Meanwhile, on the previous day, Beam Therapeutics Inc. (NASDAQ:BEAM) reported advancement across its hematology and genetic disease franchises. The company’s management emphasized continued dosing in the BEAM-302 trial for alpha-1 antitrypsin deficiency, alongside new data from BEAM-101 expected at the December ASH meeting.

The investor confidence in Beam Therapeutics Inc. (NASDAQ:BEAM) is also evident from Cathie Wood’s ARK purchase of 291,001 shares, worth $7.06 million, on November 4, 2025.

With its proprietary base editing platform, Beam Therapeutics Inc. (NASDAQ: BEAM) develops precision genetic medicines that enable targeted single-base changes for treating serious diseases.

While we acknowledge the potential of BEAM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 7 Best Oil and Gas Penny Stocks to Buy According to Analysts and Billionaire Jacob Rothschild’s RIT Capital Partners: 9 Stocks with Huge Upside Potential.

Disclosure: None.

View Comments